PATENT CLAIM ANALYSIS

Application Number: 15970635
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "476000"]

Abstract:
Described herein are compounds and compositions for treating glaucoma and/or reducing intraocular pressure. Compositions may comprise an isoquinoline compound and a prostaglandin or a prostaglandin analog. Compounds described herein include those in which an isoquinoline compound is covalently linked to a prostaglandin or a prostaglandin analog, and those in which an isoquinoline compound and a prostaglandin free acid together form a salt.

Claim (Index 53):
A composition comprising a dimesylate salt of 4-(3-amino-1-(isoquinolin-6-y1amino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.65
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15627238', '15901361', '15236625', '15142461', '14213961']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8250446040976531
- 35 USC 102 Novelty (BERT): 0.6007426739948653
- Combined Prediction Score: 0.8026144110873743
- Mean Citation Score: 499.5718920000001
- Max Citation Score: 516.87463
- Similarity Product: 499.6157314453305

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test